Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) (NCT05743517)
Patient-Tailored Physical Activity Intervention Among Older Women With Gynecologic Cancers Undergoing Chemotherapy (Fit4Treatment)
🩺 Plain-English Summary (8th-Grade Level)
The primary purpose of the study is to determine which of four components (symptom-burden tailored app, exercise partner, oncology provider engagement, coaching) added to a core intervention of a wearable activity tracker and commercially available app, will improve physical activity. The findings will generate meaningful knowledge about how to best increase physical activity in older gynecologic cancer patients receiving systemic cancer therapies to improve quality of life and cancer-specific survival.
Who can join: Review the eligibility criteria below.
Location: Northwestern University — Chicago, Illinois
Age range: 60 Years
🧪 Interventions in This Study
- Fit4Treatment (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Northwestern University — Chicago, Illinois
📞 Contact the Study Coordinator
Phone: (312) 503-4165
Email: anne@northwestern.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Ovary Cancer
- Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study — Knoxville, Tennessee
- Multimedia Aid for Genetic Testing in Gynecologic Oncology — Chapel Hill, North Carolina
- Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer — Baltimore, Maryland
- An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib — Irvine, California
- Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy — Chicago, Illinois
Explore by condition: All Ovary Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.